References
- 1. Kang JM, Shin DW, Kwon MY, et al. Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. World J Gastroenterol 2011;17(30):35183525.doi:10.3748/wjg.v17.i30.3518.10.3748/wjg.v17.i30.3518316325021941419
- 2. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-13. doi:10.1158/1055-9965.EPI-13-1057.10.1158/1055-9965.EPI-13-1057401937324618998
- 3. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut.2013;62(5):676-82.doi: 10.1136/gutjnl-2012-302240.10.1136/gutjnl-2012-302240361868722698649
- 4. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis World J Gastroenterol. 2014;20(38):13842–13862. doi:10.3748/wjg.v20.i38.13842.10.3748/wjg.v20.i38.13842419456725320521
- 5. Jennifer MY, Sue J.G, Karen MK, Majid E. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections Cancer Causes Control. 2009;20(10): 2021–2029.doi:10.1007/s10552-009-9397-9.10.1007/s10552-009-9397-9290485519642005
- 6. Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 2013;16(6):358-65. doi: 013166/AIM.0010.
- 7. Machado AM, Figueiredo C, Seruca R, Rasmussen LJ. Helicobacter pylori infection generates genetic instability in gastric cells. Biochim Biophys Acta. 2010;1806(1):58-65.doi: 10.1016/j.bbcan.2010.01.007.10.1016/j.bbcan.2010.01.00720122996
- 8. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-9.doi:10.1056/NEJMoa001999.10.1056/NEJMoa00199911556297
- 9. Watari J, Chen N, Amenta SP, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461–5473.doi:10.3748/wjg.v20.i18.5461.10.3748/wjg.v20.i18.5461401706124833876
- 10. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554–3560.
- 11. Correa P, Piazuelo MB, The gastric precancerous cascade. J Dig Dis 2012;13(1):2-9.doi: 10.1111/j.1751-2980.2011.00550.x.10.1111/j.1751-2980.2011.00550.x340460022188910
- 12. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004;7(2):61-77. doi10.1007/s10120-004-0277-4.10.1007/s10120-004-0277-415224192
- 13. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467–477.doi:10.1007/978-1-60327-492-0_23.10.1007/978-1-60327-492-0_23
- 14. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet, 1975;2:58-60.10.1016/S0140-6736(75)90498-5
- 15. Jernal A, Bray F, Center MM, et al. Globan cancer statistics. CA Cancer J Clin 2011;61:69-90.doi:10.3322/caac.20107.10.3322/caac.2010721296855
- 16. http://globocan.iarc.fr/Pages/Map.aspx
- 17. Bastos J1, Peleteiro B, Barros R, et al. Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults. Helicobacter. 2013;18(6):413-22.doi:10.1111/hel.12061.10.1111/hel.1206123725608
- 18. Saniee P, Shahreza S, Siavoshi F. Negative effect of proton-pump inhibitors (PPIs) on helicobacter pylori growth, morphology, and urease test and recovery after PPI removal - an in vitro study. Helicobacter. 2015;28.doi:10.1111/hel.12246.10.1111/hel.1224626222264
- 19. Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698-709.doi:10.1007/s10620-014-3063-0.10.1007/s10620-014-3063-024563236
- 20. Ogata SK, Kawakami E, Patrício FR, Pedroso MZ, Santos AM. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. Sao Paulo Med J. 2001;119(2):67-71.doi.org/10.1590/S1516-31802001000200006.10.1590/S1516-31802001000200006
- 21. Hahn M, Fennerty MB, Corless CL, et al. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointest Endosc. 2000;52(1):20-6. doi:http://dx.doi.org/10.1067/mge.2000.106686.
- 22. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74–94. doi:10.1055/s-0031-1291491.10.1055/s-0031-1291491336750222198778
- 23. Zullo A, Hassan C, Romiti A, et. al. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol 2012;4(3):30-36.doi:10.4251/wjgo.v4.i3.30.10.4251/wjgo.v4.i3.30331292622468181
- 24. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009;24:193–201.doi:10.1111/j.1440-1746.2008.05774.x.10.1111/j.1440-1746.2008.05774.x19215332
- 25. Kyrlagkitsis I, Karamanolis DG. Premalignant lesions and conditions for gastric adenocarcinoma: diagnosis, management and surveillance guidelines. Hepatogastroenterology. 2003;50(50):592-600.doi:10.5754/hge121268.
- 26. Lea IV, Aino MO, Pentti IS, Hilpi IKR. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol. 2010;16(1):83–88.doi:10.3748/wjg.v16.i1.83.
- 27. Faller G1, Kirchner T. Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch. 2005;446(1):1-9. doi10.1007/s00428-004-1157-3.10.1007/s00428-004-1157-315583929
- 28. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metpalasia and gastric cancer. Am J Gastroenterol 2000;95(6):1431-8doi:10.1038/ajg.2015.169.10.1038/ajg.2015.169
- 29. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010;105(3):493-8.doi:10.1038/ajg.2009.728.10.1038/ajg.2009.728289540720203636
- 30. Eriksson NK, Kärkkäinen PA, Färkkilä MA, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008;40(5):35560.doi:10.1016/j.dld.2007.12.012.10.1016/j.dld.2007.12.01218291729
- 31. Zhang C, Yamada N, Wu YL, et al. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005;14;11(6):791-6.doi:10.3748/wjg.v11.i6.791.10.3748/wjg.v11.i6.791425058515682469
- 32. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16(41):51815194.doi:10.3748/wjg.v16.i41.5181.10.3748/wjg.v16.i41.5181297508921049552
- 33. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713-39.doi:10.1128/CMR.0001110.